REFERENCES
- Parker TF, Laird NM, Lowrie EG. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int. 1983; 13: S42–S49
- Tomson CTV. Cardiovascular disease in chronic renal failure. Comprehensive Clinical Nephrology 2nd, RJ Johnson, J Feehally. Mosby, Toronto 2003; 887–912
- Port FK. Morbidity and mortality in dialysis patients. Kidney Int. 1994; 46: 1728–1737
- Barsum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006; 354: 997–999
- Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyren O, Fored CM. The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis. 2005; 46(5)863–870
- Zoccali C. Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int. 2006; 70(1)26–33
- Wang AY. Prognostic value of C-reactive protein for heart disease in dialysis patients. Curr Opin Investig Drugs. 2005; 6(9)879–886
- Raymond T, Kredie T. How to preserve residual renal function in patients with chronIc kidney disease and on dialysis?. Nephrology Dialysis Transplantation 2006; 21(Suppl. 2)II42–II46
- Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis. 2005; 45(6)1058–1066
- Abbott KC, Agodoa LY. Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol. 2001; 56(2)124–131
- Wasse H, Gillen DL, Ball AM, et al. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int. 2003; 64(4)1455–1461
- Tveit DP, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC. Risk factors for pulmonary embolism in chronic dialysis patients. J Nephrol. 2002; 15(3)241–7
- Delmez JA, Yan G, Bailey J, et al. Hemodialysis (HEMO) Study Group. Cerebrovascular disease in maintenance hemodialysis patients: Results of the HEMO Study. Am J Kidney Dis. 2006; 47(1)131–138
- Erek E, Süleymanlar G, Serdengeçti K. TND—Registry of the Nephrology Dialysis and Transplantation in Turkey, Registry 2005. Publications of the Turkish Society of Nephrology (TSN), Istanbul 2006
- Yao Q, Axelsson J, Stenvinkel P, Lindholm B. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J. 2004; 50(6)lii–lvii
- Muntner P, Coresh J, Powe NR, Klag MJ. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol. 2003; 14(6)1568–1577
- Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol. 2005; 25(6)358–362
- Portoles J, Lopez-Gomez JM, Aljama P. Cardiovascular risk in hemodialysis in Spain: Prevalence, management and target results (MAR Study). Nefrologia. 2005; 25(3)297–306
- Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005; 68(2)766–772
- Kobus G, Malyszko J, Mysyliwiec M. Cardiovascular risk factors in dialyzed patients. Pol Arch Med Wewn. 2004; 112(6)1425–1431
- Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006; 47(1)139–148
- Collins A, Li S, Ma J, et al. Cardiovascular disease in end stage renal disease patients. Am J Kidney Dis. 2001; 38: 26–29
- Pozzoni P, Del Vecchio L, Locatelli F. Anemia treatment to reduce mortality risk and to improve quality of life in chronic uremic patients. G Ital Nefrol. 2005; 22(Suppl. 31)S41–S46
- Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005; 16(Suppl. 1)S83–S88
- Di Benedetto A, Marcelli D, D'Andrea A, et al. Risk factors and underlying cardiovascular diseases in incident ESRD patients. J Nephrol. 2005; 18(5)592–598
- Don BR, Kaysen G. Serum albumin: Relationship to inflammation and nutrition. Semin Dial. 2004; 16(6)432–437
- Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004; 43(1)61–66
- Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004; 65(3)1031–1040
- Drüeke TB, Locatelli F, Clyne N, , for the CREATE Investigators, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006; 355: 2071–2084
- Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?. Semin Dial. 2005; 18(5)365–369
- Nissenson AR, Dylan ML, Griffiths RI, et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis. 2005; 46(2)301–308
- Pai MF, Hsu SP, Peng YS, Hung KY, Tsai TJ. Hemorrhagic stroke in chronic dialysis patients. Ren Fail. 2004; 26(2)165–170
- K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005; 45(4 Suppl. 3)S1–S153
- Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ, Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group. Risk factors for early mortality in U.S. peritoneal dialysis patients: Impact of residual renal function. Perit Dial Int. 2002; 22(3)371–379